Xtl Biopharmaceuticals (XTLB) EBIT (2009 - 2024)
Xtl Biopharmaceuticals' EBIT was -$1.69 million in the year ended Dec 31, 2025, compared with -$775,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) EBIT (2009 - 2024) Analysis & Trends
From the year ended Dec 31, 2009 onward, Xtl Biopharmaceuticals has reported EBIT for 17 years.
- The figure for the year ended Dec 31, 2025 marks the lowest annual EBIT since the year ended Dec 31, 2016.
- Per Business Quant data, EBIT in earlier years was -$775,000 in the year ended Dec 31, 2024, -$765,000 in the year ended Dec 31, 2023, -$880,000 in the year ended Dec 31, 2022 and -$1.03 million in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,156.65 Bn | 1,125.24 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.47 Bn | 542.00 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 513.29 Bn | 486.41 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 365.54 Bn | 319.91 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.49 Bn | 261.48 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.70 Bn | 235.39 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 235.24 Bn | 190.64 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 193.50 Bn | 167.70 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.03 Bn | 118.68 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 585,000.00 |
| Sep 30, 2024 | -764,000.00 |
| Jun 30, 2024 | -421,000.00 |
| Mar 31, 2024 | -175,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | -151,000.00 |
| Jun 30, 2023 | -163,000.00 |
| Mar 31, 2023 | -251,000.00 |
| Dec 31, 2022 | -225,000.00 |
| Sep 30, 2022 | -204,000.00 |
| Jun 30, 2022 | -202,000.00 |
| Mar 31, 2022 | -249,000.00 |
| Dec 31, 2021 | -286,000.00 |
| Sep 30, 2021 | -210,000.00 |
| Jun 30, 2021 | -303,000.00 |
| Mar 31, 2021 | -232,000.00 |
| Dec 31, 2020 | -257,000.00 |
| Sep 30, 2020 | -217,000.00 |
| Jun 30, 2020 | -217,000.00 |
| Mar 31, 2020 | -257,000.00 |
API Access
Xtl Biopharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();